Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Cheng Website

Sheue-yann Cheng, Ph.D.

Selected Publications

1)  Fozzatti L, Lu C, Kim DW, Park JW, Astapova I, Gavrilova O, Willingham MC, Hollenberg AN, Cheng SY.
Resistance to thyroid hormone is modulated in vivo by the nuclear receptor corepressor (NCOR1).
Proc. Natl. Acad. Sci. U.S.A. 108: 17462-7, 2011.
[Journal]
2)  Kim WG, Guigon CJ, Fozzatti L, Park JW, Lu C, Willingham MC, Cheng SY.
SKI-606, an Src inhibitor, reduces tumor growth, invasion, and distant metastasis in a mouse model of thyroid cancer.
Clin. Cancer Res. 18: 1281-90, 2012.
[Journal]
3)  Fozzatti L, Kim DW, Park JW, Willingham MC, Hollenberg AN, Cheng S.
Nuclear receptor corepressor (NCOR1) regulates in vivo actions of a mutated thyroid hormone receptor a.
Proc. Natl. Acad. Sci. U.S.A. 110: 7850-7855, 2013.
[Journal]
4)  Kim W, Park J, Willingham M, Cheng S.
Diet-induced obesity increases tumor growth and promotes anaplastic change in thyroid cancer in a mouse model.
Endocrinology. 154: 2936-2947, 2013.
[Journal]
5)  Fozzatti L, Park J, Zhao L, Willingham M, Cheng S.
Oncogenic actions of the nuclear receptor corepressor (NCOR1) in a mouse model of thyroid cancer.
PLOS One 8. e67954, 2013.
[Journal]
Click Here to View Expanded Bibliography.

This page was last updated on 12/9/2013.